Actemra 160mg, a drug known scientifically as tocilizumab, functions as a potent therapeutical agent primarily employed for the treatment of rheumatoid arthritis. This remarkable compound operates by interfering with the activity of interleukin-6 (IL-6), a regulatory protein essential in the inflammatory process. Additionally, Actemra demonstrates